Search

Your search keyword '"Nagai, Ryozo"' showing total 3,228 results

Search Constraints

Start Over You searched for: Author "Nagai, Ryozo" Remove constraint Author: "Nagai, Ryozo"
3,228 results on '"Nagai, Ryozo"'

Search Results

4. Serum mature and furin-cleaved proprotein convertase subtilisin/kexin type 9 levels and their association with cardiovascular events in statin-treated patients with cardiovascular disease

5. Differential prediction of high-sensitivity cardiac troponin-I, but not N-terminal pro-brain natriuretic peptide, in different pitavastatin doses on cardiovascular events in stable coronary artery disease

6. Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events

7. Plasma ANGPTL8 Levels and Risk for Secondary Cardiovascular Events in Japanese Patients With Stable Coronary Artery Disease Receiving Statin Therapy

8. Heart failure promotes multimorbidity through innate immune memory

9. Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular events

11. Optimizing Timing of Intraperitoneal Chemotherapy to Enhance Intravenous Carboplatin Concentration.

14. Association between Non-Lipid Residual Risk Factors and Cardiovascular Events in Patients with Stable Coronary Artery Disease Treated with Pitavastatin: An Observation from the REAL-CAD Study

15. Relation of renal function to mid-term prognosis of stable angina patients with high- or low-dose pitavastatin treatment: REAL-CAD substudy

18. BNP level predicts bleeding event in patients with heart failure after percutaneous coronary intervention

20. Cardiac macrophages prevent sudden death during heart stress

21. Corrigendum to “Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events” [Int. J. Cardiol. Cardiovasc. Risk and Prev. 2023 Jun 25:18:200193]

22. Metabolomic Profiling of Mice with Tacrolimus-Induced Nephrotoxicity: Carnitine Deficiency in Renal Tissue.

23. A Potent PDK4 Inhibitor for Treatment of Heart Failure with Reduced Ejection Fraction.

24. Residual Coronary Risk Factors Associated With Long-Term Clinical Outcomes in Patients With Coronary Artery Disease Treated With High- vs. Low-Dose Statin Therapy ― REAL-CAD Substudy ―

29. Association between the ratio of serum n-3 to n-6 polyunsaturated fatty acids and acute coronary syndrome in non-obese patients with coronary risk factor: a multicenter cross-sectional study

33. Data from A Nanoparticle System Specifically Designed to Deliver Short Interfering RNA Inhibits Tumor Growth In vivo

35. Data from Vaccination with Antigen-Transfected, NKT Cell Ligand–Loaded, Human Cells Elicits Robust In Situ Immune Responses by Dendritic Cells

41. Supplementary Methods, Figures 1-8, Tables 1-2 from A Nanoparticle System Specifically Designed to Deliver Short Interfering RNA Inhibits Tumor Growth In vivo

42. Supplementary Methods from Vaccination with Antigen-Transfected, NKT Cell Ligand–Loaded, Human Cells Elicits Robust In Situ Immune Responses by Dendritic Cells

43. Relationships Among Heart Rate, β-Blocker Dosage, and Prognosis in Patients With Coronary Artery Disease in a Real-World Database Using a Multimodal Data Acquisition System

44. Low-Density Lipoprotein Cholesterol Levels on Statins and Cardiovascular Event Risk in Stable Coronary Artery Disease ― An Observation From the REAL-CAD Study ―

45. Hyperuricemia predicts increased cardiovascular events in patients with chronic coronary syndrome after percutaneous coronary intervention: A nationwide cohort study from Japan

49. Macrophage hypoxia signaling regulates cardiac fibrosis via Oncostatin M

Catalog

Books, media, physical & digital resources